Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5001 | 1690 | 45.1 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
631 | 3 | KYNURENINE//NEOPTERIN//INDOLEAMINE 2 3 DIOXYGENASE | 12928 |
2074 | 2 | KYNURENINE//NEOPTERIN//INDOLEAMINE 2 3 DIOXYGENASE | 5255 |
5001 | 1 | KYNURENIC ACID//KYNURENINE//QUINOLINIC ACID | 1690 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | KYNURENIC ACID | authKW | 3998597 | 21% | 64% | 347 |
2 | KYNURENINE | authKW | 2021421 | 16% | 41% | 273 |
3 | QUINOLINIC ACID | authKW | 1892935 | 15% | 42% | 252 |
4 | KYNURENINE PATHWAY | authKW | 1349305 | 7% | 66% | 114 |
5 | KYNURENINE AMINOTRANSFERASE | authKW | 920832 | 3% | 88% | 58 |
6 | 3 HYDROXYKYNURENINE | authKW | 763123 | 4% | 68% | 62 |
7 | PHYSIOL ANAT NEUROSCI | address | 328558 | 3% | 37% | 49 |
8 | KYNURENINE 3 MONOOXYGENASE | authKW | 254495 | 1% | 78% | 18 |
9 | KYNURENINASE | authKW | 192699 | 1% | 67% | 16 |
10 | MARYLAND PSYCHIAT | address | 190196 | 6% | 11% | 100 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 10447 | 46% | 0% | 776 |
2 | Pharmacology & Pharmacy | 1293 | 18% | 0% | 307 |
3 | Biochemistry & Molecular Biology | 1098 | 24% | 0% | 413 |
4 | Clinical Neurology | 611 | 10% | 0% | 164 |
5 | Psychiatry | 304 | 6% | 0% | 100 |
6 | Medicine, Research & Experimental | 228 | 6% | 0% | 93 |
7 | Chemistry, Analytical | 131 | 5% | 0% | 90 |
8 | Chemistry, Medicinal | 124 | 3% | 0% | 56 |
9 | Biochemical Research Methods | 87 | 3% | 0% | 57 |
10 | Physiology | 69 | 3% | 0% | 55 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHYSIOL ANAT NEUROSCI | 328558 | 3% | 37% | 49 |
2 | MARYLAND PSYCHIAT | 190196 | 6% | 11% | 100 |
3 | AMINOACIDOS EXCITADO | 98331 | 1% | 26% | 21 |
4 | RAY WILLIAMS BIOMED MASS SPE OMETRY IL | 95078 | 1% | 53% | 10 |
5 | PSYCHIAT INFLAMMAT PROGRAM | 81296 | 0% | 75% | 6 |
6 | ALBERT SZENT GYORGYI CLIN | 74430 | 2% | 14% | 29 |
7 | MTA SZTE NEUROSCI GRP | 70504 | 1% | 35% | 11 |
8 | MED MARYLAND PSYCHIAT | 68090 | 0% | 54% | 7 |
9 | NEUROL GRP | 62130 | 1% | 20% | 17 |
10 | AUSTRALASIAN | 56272 | 1% | 35% | 9 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF NEURAL TRANSMISSION | 10577 | 3% | 1% | 49 |
2 | JOURNAL OF NEUROCHEMISTRY | 4915 | 4% | 0% | 76 |
3 | EXPERIMENTAL NEUROLOGY | 2604 | 2% | 0% | 37 |
4 | NEUROSCIENCE LETTERS | 2364 | 4% | 0% | 65 |
5 | NEUROPHARMACOLOGY | 2049 | 2% | 0% | 33 |
6 | PHARMACOLOGICAL REPORTS | 1952 | 1% | 1% | 14 |
7 | BRAIN RESEARCH | 1769 | 4% | 0% | 70 |
8 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 1683 | 2% | 0% | 40 |
9 | FARMAKOLOGIYA I TOKSIKOLOGIYA | 1471 | 1% | 1% | 10 |
10 | REDOX REPORT | 1220 | 0% | 1% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | KYNURENIC ACID | 3998597 | 21% | 64% | 347 | Search KYNURENIC+ACID | Search KYNURENIC+ACID |
2 | KYNURENINE | 2021421 | 16% | 41% | 273 | Search KYNURENINE | Search KYNURENINE |
3 | QUINOLINIC ACID | 1892935 | 15% | 42% | 252 | Search QUINOLINIC+ACID | Search QUINOLINIC+ACID |
4 | KYNURENINE PATHWAY | 1349305 | 7% | 66% | 114 | Search KYNURENINE+PATHWAY | Search KYNURENINE+PATHWAY |
5 | KYNURENINE AMINOTRANSFERASE | 920832 | 3% | 88% | 58 | Search KYNURENINE+AMINOTRANSFERASE | Search KYNURENINE+AMINOTRANSFERASE |
6 | 3 HYDROXYKYNURENINE | 763123 | 4% | 68% | 62 | Search 3+HYDROXYKYNURENINE | Search 3+HYDROXYKYNURENINE |
7 | KYNURENINE 3 MONOOXYGENASE | 254495 | 1% | 78% | 18 | Search KYNURENINE+3+MONOOXYGENASE | Search KYNURENINE+3+MONOOXYGENASE |
8 | KYNURENINASE | 192699 | 1% | 67% | 16 | Search KYNURENINASE | Search KYNURENINASE |
9 | KYNURENINE 3 HYDROXYLASE | 150551 | 1% | 83% | 10 | Search KYNURENINE+3+HYDROXYLASE | Search KYNURENINE+3+HYDROXYLASE |
10 | XANTHURENIC ACID | 141007 | 1% | 35% | 22 | Search XANTHURENIC+ACID | Search XANTHURENIC+ACID |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHWARCZ, R , BRUNO, JP , MUCHOWSKI, PJ , WU, HQ , (2012) KYNURENINES IN THE MAMMALIAN BRAIN: WHEN PHYSIOLOGY MEETS PATHOLOGY.NATURE REVIEWS NEUROSCIENCE. VOL. 13. ISSUE 7. P. 465 -477 | 147 | 76% | 261 |
2 | LOVELACE, MD , VARNEY, B , SUNDARAM, G , LENNON, MJ , LIM, CK , JACOBS, K , GUILLEMIN, GJ , BREW, BJ , (2017) RECENT EVIDENCE FOR AN EXPANDED ROLE OF THE KYNURENINE PATHWAY OF TRYPTOPHAN METABOLISM IN NEUROLOGICAL DISEASES.NEUROPHARMACOLOGY. VOL. 112. ISSUE . P. 373 -388 | 82 | 50% | 4 |
3 | FUJIGAKI, H , YAMAMOTO, Y , SAITO, K , (2017) L-TRYPTOPHAN-KYNURENINE PATHWAY ENZYMES ARE THERAPEUTIC TARGET FOR NEUROPSYCHIATRIC DISEASES: FOCUS ON CELL TYPE DIFFERENCES.NEUROPHARMACOLOGY. VOL. 112. ISSUE . P. 264 -274 | 104 | 65% | 1 |
4 | VECSEI, L , SZALARDY, L , FULOP, F , TOLDI, J , (2013) KYNURENINES IN THE CNS: RECENT ADVANCES AND NEW QUESTIONS.NATURE REVIEWS DRUG DISCOVERY. VOL. 12. ISSUE 1. P. 64 -82 | 122 | 57% | 107 |
5 | STONE, TW , (2001) KYNURENINES IN THE CNS: FROM ENDOGENOUS OBSCURITY TO THERAPEUTIC IMPORTANCE.PROGRESS IN NEUROBIOLOGY. VOL. 64. ISSUE 2. P. 185 -218 | 188 | 61% | 192 |
6 | ERHARDT, S , SCHWIELER, L , IMBEAULT, S , ENGBERG, G , (2017) THE KYNURENINE PATHWAY IN SCHIZOPHRENIA AND BIPOLAR DISORDER.NEUROPHARMACOLOGY. VOL. 112. ISSUE . P. 297 -306 | 78 | 55% | 2 |
7 | NOTARANGELO, FM , POCIVAYSEK, A , (2017) ELEVATED KYNURENINE PATHWAY METABOLISM DURING NEURODEVELOPMENT: IMPLICATIONS FOR BRAIN AND BEHAVIOR.NEUROPHARMACOLOGY. VOL. 112. ISSUE . P. 275 -285 | 78 | 53% | 2 |
8 | ZADORI, D , VERES, G , SZALARDY, L , KLIVENYI, P , FULOP, F , TOLDI, J , VECSEI, L , (2016) INHIBITORS OF THE KYNURENINE PATHWAY AS NEUROTHERAPEUTICS: A PATENT REVIEW (2012-2015).EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 26. ISSUE 7. P. 815 -832 | 107 | 80% | 0 |
9 | O'FARRELL, K , HARKIN, A , (2017) STRESS-RELATED REGULATION OF THE KYNURENINE PATHWAY: RELEVANCE TO NEUROPSYCHIATRIC AND DEGENERATIVE DISORDERS.NEUROPHARMACOLOGY. VOL. 112. ISSUE . P. 307 -323 | 100 | 48% | 1 |
10 | OCAMPO, JR , HUITRON, RL , GONZALEZ-ESQUIVEL, D , UGALDE-MUNIZ, P , JIMENEZ-ANGUIANO, A , PINEDA, B , PEDRAZA-CHAVERRI, J , RIOS, C , DE LA CRUZ, VP , (2014) KYNURENINES WITH NEUROACTIVE AND REDOX PROPERTIES: RELEVANCE TO AGING AND BRAIN DISEASES.OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. VOL. . ISSUE . P. - | 130 | 60% | 6 |
Classes with closest relation at Level 1 |